BORUZU
NDC 70121-2484, Bortezomib, injection, from Amneal Pharmaceuticals LLC.
- Product NDC
- 70121-2484
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212782
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70121-2484 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BORTEZOMIB3.5 mg/1.4mL
Pharmacologic classes
Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70121-2484-1 | 70121248401 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-2484-1) / 1.4 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b92628dd-fa09-4c3a-b6a3-66426025807cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70121-2484
Use it
Look up 70121-2484 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70121-2484 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70121-2484. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.